InvestorsHub Logo
Followers 57
Posts 11397
Boards Moderated 0
Alias Born 02/09/2009

Re: None

Tuesday, 04/12/2022 10:54:34 AM

Tuesday, April 12, 2022 10:54:34 AM

Post# of 547
Minor news release this morning

10:39 AM EDT, 04/12/2022 (MT Newswires) reported that a preclinical study for the treatment of rheumatoid arthritis bested the effect competitive therapies by 30% to 70%, and also said that an IND was planned in H2 of this year.

I'd copy the release here except that it's copyrighted.

This is almost certainly a report on the trial we have been discussing. Perhaps released only to allow searches on "rheumatoid arthritis" to find it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News